Genenta Science Spa Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Genenta Science CEO Pierluigi Paracchi acquired 100,000 stock options with an exercise price of $0.63, vesting over three years.
NASDAQ
Genenta Science's CMO and Head of Development, Francesco Galimi, acquired 20,000 stock options with an exercise price of $0.63, vesting over one year starting March 30, 2026.
NASDAQ
Genenta Science S.p.A.'s Chief Financial Officer, Richard B. Slansky, was granted 80,000 stock options with an exercise price of $0.63, vesting monthly over three years starting March 30, 2026.